Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan
- DOI
- 10.6084/m9.figshare.c.5465206.v1
- Published
- 2021
- Container
- Not recorded
- Publisher
- figshare
- Open access
- yes
Credibility signals
limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.6084/m9.figshare.c.5465206.v1,
title = {Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan},
author = {Huang, Yu-Ting and Hsieh, Yung-Yu and Chen, Wei-Ming and Tung, Shui-Yi and Wei, Kuo-Liang and Shen, Chen-Heng and Chang, Kao-Chi and Lu, Chung-Kuang and Yen, Chih-Wei and Lu, Sheng-Nan and Hung, Chao-Hung and Chang, Te-Sheng},
year = {2021},
doi = {10.6084/m9.figshare.c.5465206.v1},
url = {https://doi.org/10.6084/m9.figshare.c.5465206.v1}
}RIS
TY - JOUR TI - Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan AU - Huang, Yu-Ting AU - Hsieh, Yung-Yu AU - Chen, Wei-Ming AU - Tung, Shui-Yi AU - Wei, Kuo-Liang AU - Shen, Chen-Heng AU - Chang, Kao-Chi AU - Lu, Chung-Kuang AU - Yen, Chih-Wei AU - Lu, Sheng-Nan AU - Hung, Chao-Hung AU - Chang, Te-Sheng PY - 2021 DO - 10.6084/m9.figshare.c.5465206.v1 UR - https://doi.org/10.6084/m9.figshare.c.5465206.v1 ER -
APA
Yu-Ting, H., Yung-Yu, H., Wei-Ming, C., Shui-Yi, T., Kuo-Liang, W., Chen-Heng, S., Kao-Chi, C., Chung-Kuang, L., Chih-Wei, Y., Sheng-Nan, L., Chao-Hung, H., & Te-Sheng, C. (2021). Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan. https://doi.org/10.6084/m9.figshare.c.5465206.v1
Source records
- datacite · retrieved 2026-09-26T23:13:10.141Z